Company
Aperiam Bio
Improving Billions of Lives with Designer Proteins
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Customers
- our partners
Claim, correct or request removal
Record updated 17 September 2026
About
We identify hyperfolding variants of a target protein with ten fold improved expression, solubility, and specific activity.
Funding snapshot
- Total raised
- $9MSum of rounds, as of 2026-09-17Source (opens in a new tab)
- Latest round
- Undisclosed, $9M2023-11-29
Funding rounds
- Round, 2023
- $9M2023-11-29, Company stated
Products
- Other
- Cosmetics
- Other
- Pulmonary Biologics
- Other
- Technical Reagents
Loading relationship preview